期刊文献+

血清基质金属蛋白酶-3与类风湿关节炎的相关性研究 被引量:9

Correlation of Matrix Metalloproteinases-3 and Rheumatoid Arthritis
下载PDF
导出
摘要 目的探讨血清基质金属蛋白酶-3(matrix metalloproteinases-3,MMP-3)与类风湿关节炎(rheumatoid arthritis,RA)及其炎症反应的相关性。方法用免疫比浊法(immunoturbidimetric assays)检测146例RA患者(RA组)及232例非RA人群(对照组)血清MMP-3水平;对两组MMP-3结果进行ROC曲线分析;分析RA患者血清MMP-3与反映RA患者炎症活动程度临床指标的关系。结果 RA组血清MMP-3浓度为170.00±19.36ng/mL,明显高于对照组的47.92±1.98ng/mL,差异有统计学意义(P<0.001)。血清MMP-3诊断RA的ROC曲线下面积为0.731,取诊断界限值为71.65ng/mL时,敏感度为58.9%,特异度为88.79%。RA组患者血清MMP-3水平与其他RA诊断以及反应RA炎症反应的指标,如C反应蛋白(C-reaction protein,CRP)、前白蛋白(prealbumin,PA)、血沉(erythrocyte sedimentation rate,ESR)、血小板(platelet)以及白细胞计数(WBC)均具有显著相关性,P值均<0.001。结论RA患者血清MMP-3水平显著高于正常人,其水平与反映RA患者炎症活动程度临床指标CRP、PA、ESR、PLT以及WBC具有显著相关性。类风湿性关节炎患者血清MMP-3水平与类风湿性关节炎的炎症活动性有关。 Objective To investigate the relationship between serum matrix metalloproteinase-3 and rheumatoid arthritis. Methods The serum MMP-3 level in 146 patients with RA and 232 non RA patients were detected by immunoturbidimetry. The receiver operating Curve (ROC) analysis was carried out to get the cut- off value. The relationship between MMP-3 and other clinical biochemical indices were analyzed by multiple regressions. Results The serum MMP-3 concentration in RA group( 170 ±19.36 ng/mL) was significantly higher than that of control group(47.92 ± 1.98 ng/mL,P 〈0.001 ). The optimal diagnostic cut-off value for MMP-3 was 71.65 ng/mL. The sensitivity and specificity were 58.9% and 88.79% respectively at this cut-off value. The serum concentration of MMP-3 in RA patients was significantly correlated with inflammation and activity indices such as C-reaction protein, prealbumin, erythrocyte sedimentation rate, platelet, white blood cell count( P 〈 0. 001 ). Conclusion The serum MMP-3 levels in patients with rheumatoid arthritis is correlated to inflammatory activity.
出处 《标记免疫分析与临床》 CAS 2014年第6期636-639,共4页 Labeled Immunoassays and Clinical Medicine
关键词 血清基质金属蛋白酶-3 类风湿关节炎 受试者工作曲线 敏感度 特异度 Matrix metalloproteinase-3 Specificity Rheumatoid arthritis Receiver operating curve Sensitivity Specificity
  • 相关文献

参考文献10

  • 1Mclnnes I B,Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med, 2011,365(23) : 2205-2219.
  • 2Hamakawa H, Takemura M, Sato M, et al. [ Clinical significance of MMP-3 in patients with rheumatoid arthritis: comparison with other ,inflammatory markers( IL-6, IL-8) ]. Rinsho Byori, 2003,51 ( 1 ) : 13-18.
  • 3Mjaavatten M D, Bykerk V P. Early rheumatoid arthritis: the performance of the 2010 ACR/EULAR criteria for diagnosing RA. Best Praet Res Clin Rheumatol, 2013,27(4) : 451-466.
  • 4Yamanaka H, Matsuda Y, Tanaka M, et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum, 2000,43 (4) : 852-858.
  • 5Huang J, Xie B,Li Q, et al. Infliximab reduces CD147, MMP-3, and MMP-9 expression in peripheral blood monocytes in patients with active rheumatoid arthritis. Eur J Pharmaeol, 2013,698 ( 1- 3) : 429-434.
  • 6Tian J, Chen J W,Gao J S,et al. Resveratrel inhibits TNF-alpha- induced IL-1 beta, M MP-3 produetion in human rheumatoid arthritis fibroblast-like synovioeytes via modulation of PI3kinase/Akt pathway. Rheumatol Int, 2013,33(7) : 1829-1835.
  • 7van Hamburg J P, Corneth O B,Paulissen S M,et al. IL-17/ThI7 mediated synovial inflammation is IL-22 independent. Ann Rheum Dis, 2013, 72(10) : 1700-1707.
  • 8de Seny D, Cobraiville G, Charlier E, et al. Acute-phase serum amyloid a in osteoarthritis : regulatory mechanism and proinflammatory properties. PLoS One, 2013,8(6) : 667-669.
  • 9Ma J D,Zhou J J,Zheng D H,et al. Serum matrix metallopreteinase- 3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis. Mediators Inflamm, 2014 : 179284.
  • 10Matsuno H ,Yudoh K,Watanabe Y, et al. Stromelysin- 1 ( MICIP-3 ) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand. J Rheumatol, 2001, 28 ( 1 ) : 22-28.

同被引文献63

  • 1李婉秋,孙林,张戈.心血管疾病中JAK-STAT通路研究进展[J].昆明医科大学学报,2012,33(S1):11-13. 被引量:3
  • 2MeInnes IB, Schett G. The pathogenesis of rheumatoid arthritis [J]. N Eng J Med, 2011, 365(23) : 2205 -2219.
  • 3Lzumi K, Karneda H. Prediclion of efficacy of molecular targeted agents for rheumatoid arthritis[ J]. Nihon Rinsho, 2012, 70(8) : 658 - 663.
  • 4Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheu- matism Association 1987 revised criteria for the classificaJion ofrheumatoid arthritis [ J ]. Arthritis Heum, 1988, 31 ( 18 ) : 315 - 324.
  • 5Lee EG, Lee SL, Chae HJ, et al. Ethyl acetate fraction from Cud- rania tricuspidata inhibits IL - 113 - induced rheumatoid synovial fibroblast proliferation and MMPs, COX -2 and PGE2 production [J]. BiolRes, 2010, 43(2): 225 -231.
  • 6Hashimoto M, Mimori T. Role of Thl7 cells and innate immunity for the induction of autoimmune arthritis[J]. Nihon Rinsho Mene- ki Gakkai Kaishi, 2012, 35(6) : 463 -469.
  • 7Kim J, Kang S, Kim J, et al. Elevated levels of T helper 17 cellsare associated with dsease activity in patients with rheumatoid ar- thritis[J], Ann Lab Med, 2013, 33(1): 52-59.
  • 8Tang CH, Chuang JY, Fong YC, et al. Bone - derived SDF - 1 stimulates IL - 6 release via CXCR4, ERK and NF - kb pathways and promotes osteoelastogenesis in human oral cancer cells [ J]. Carcinogenesis, 2008, 29 (8) : 1483 - 1492.
  • 9de Seny D, Cobraiville C, Charlier E, et al. Acute - phase serum amyloid a in osteoarthritis: regulatory mechanism and proinflamma- tory properties[ J]. PLOS One, 2013, 8(6) : 667 -669.
  • 10van Hamburg JP, Cometh OB, Paulisssen SM, et al. IL - 17/ Thl7 mediated synovial inflammation is IL- 22 indepenfent [ J l. Ann Aheudis, 2013, 72(10) : 1700 -1707.

引证文献9

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部